Borderline Brenner Tumor: A Review of the Literature.
Zheng R, Heller DS.
Arch Pathol Lab Med. 2019 Oct;143(10):1278-1280. doi: 10.5858/arpa.2018-0285-RS. Epub 2019 Feb 19.
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
Borderline Brenner Tumor of the Ovary Coexisting With an Ovarian Mucinous Cystadenoma With Focal Atypical Epithelial Proliferation: A Rare Case With Review of the Literature.
Salibay CJ, Zanfagnin V, Miller H, Walia S, Brunette LL, Wang T.
Int J Surg Pathol. 2021 Oct;29(7):788-793. doi: 10.1177/1066896921999459. Epub 2021 Feb 26.
Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
Kurata Y, Kido A, Moribata Y, Kameyama K, Minamiguchi S, Konishi I, Togashi K.
Magn Reson Med Sci. 2018 Jul 10;17(3):211-217. doi: 10.2463/mrms.mp.2017-0055. Epub 2017 Oct 6.
[Endometriosis-related ovarian tumors].
Schmidt D, Ulrich U.
Pathologe. 2014 Jul;35(4):348-54. doi: 10.1007/s00292-014-1949-4.
[Serous ovarian tumors].
Diebold J.
Pathologe. 2014 Jul;35(4):314-21. doi: 10.1007/s00292-014-1906-2.
Cells of Benign and Borderline Thyroid Tumor Express Malignancy Markers.
Abrosimov AY, Dvinskikh NY, Sidorin AV.
Bull Exp Biol Med. 2016 Mar;160(5):698-701. doi: 10.1007/s10517-016-3253-1. Epub 2016 Mar 29.
[Endocrine and neuroendocrine tumors].
Riss P, Scheuba K, Strobel O.
Chirurg. 2021 Nov;92(11):996-1002. doi: 10.1007/s00104-021-01512-8. Epub 2021 Oct 7.
Ovarian borderline mucinous tumor with squamous overgrowth: An unusual finding with review of literature.
Vasudevan G, Jaiprakash P, Guruvare S, Samanta N.
Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):261-263. doi: 10.4103/IJPM.IJPM_30_17.
Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis.
Madeira K, Dondossola ER, Farias BF, Simon CS, Alexandre MC, Silva BR, Rosa MI.
An Acad Bras Cienc. 2016 May 31;88(2):923-32. doi: 10.1590/0001-3765201620150107.
